RATIONALLY DESIGNED DIPEPTOID ANALOGS OF CHOLECYSTOKININ (CCK) - N-TERMINAL STRUCTURE AFFINITY RELATIONSHIPS OF ALPHA-METHYL-TRYPTOPHAN DERIVATIVES

被引:10
作者
EDEN, JM [1 ]
HIGGINBOTTOM, M [1 ]
HILL, DR [1 ]
HORWELL, DC [1 ]
HUNTER, JC [1 ]
MARTIN, K [1 ]
PRITCHARD, MC [1 ]
RAHMAN, SS [1 ]
RICHARDSON, RS [1 ]
ROBERTS, E [1 ]
机构
[1] PARKE DAVIS NEUROSCI RES CTR,ADDENBROOKES HOSP SITE,HILLS RD,CAMBRIDGE CB2 2QB,ENGLAND
关键词
CHOLECYSTOKININ; DIPEPTOID ANALOGS; STRUCTURE AFFINITY RELATIONSHIPS; ALPHA-METHYL-TRYPTOPHAN DERIVATIVES; N-TERMINAL;
D O I
10.1016/0223-5234(93)90077-R
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The structure-affinity relationships (SAR) between the N-terminii of a series of alpha-methyl-tryptophanylphenethylamide derivatives and the cholecystokinin (CCK) B receptor are discussed. A series of compounds with the general formula R-X-alpha-methyl-tryptophanylphenethylamide was prepared, where R is a cycloalkyl, a bicycloalkyl or a tricycloalkyl group and X is a urethane, thiourethane, amide, urea or a sulphinamide linking group. The CCK-B receptor binding affinities of these are discussed. The SAR form part of a systematic program for the rational design of 'dipeptoid' analogues of the neuropeptide CCK. Beginning with 1,1-dimethylpropyl (+/-)-[1-(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-[(2-phenylethyl)amino]ethyl]carbamate (IC50 = 4720 nM on CCK-B binding affinity) the N-terminal moiety was systematically changed for groups of varying size, shape and lipophilicity until the optimal N-terminal group was obtained and the favoured linking group chosen, resulting in the compound tricyclo[3.3.1.1(3,7)]dec-2-yl(R)-[(1H-indol-3-ylmethyl)-1-methyl-2-oxo-2-[(2-phenylethyl)amino]ethyl]carbamate with an IC50 = 32 nM on CCK-B receptor binding affinity.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 28 条
  • [1] AUDRY E, 1986, J MED CHEM CHIM THER, V24, P71
  • [2] CHOLECYSTOKININ IN THE CENTRAL NERVOUS-SYSTEM - A MINIREVIEW
    BEINFELD, MC
    [J]. NEUROPEPTIDES, 1983, 3 (06) : 411 - 427
  • [3] BENZODIAZEPINE GASTRIN AND BRAIN CHOLECYSTOKININ RECEPTOR LIGANDS - L-365,260
    BOCK, MG
    DIPARDO, RM
    EVANS, BE
    RITTLE, KE
    WHITTER, WL
    VEBER, DF
    ANDERSON, PS
    FREIDINGER, RM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) : 13 - 16
  • [4] BROTO P, 1984, EUR J MED CHEM, V19, P71
  • [6] A POTENT NONPEPTIDE CHOLECYSTOKININ ANTAGONIST SELECTIVE FOR PERIPHERAL-TISSUES ISOLATED FROM ASPERGILLUS-ALLIACEUS
    CHANG, RSL
    LOTTI, VJ
    MONAGHAN, RL
    BIRNBAUM, J
    STAPLEY, EO
    GOETZ, MA
    ALBERSSCHONBERG, G
    PATCHETT, AA
    LIESCH, JM
    HENSENS, OD
    SPRINGER, JP
    [J]. SCIENCE, 1985, 230 (4722) : 177 - 179
  • [7] IMMUNOCHEMICAL EVIDENCE OF CHOLECYSTOKININ-LIKE PEPTIDES IN BRAIN
    DOCKRAY, GJ
    [J]. NATURE, 1976, 264 (5586) : 568 - 570
  • [8] EDEN J, 1993, EUR J MED CHEM, P47
  • [9] DESIGN OF POTENT, ORALLY EFFECTIVE, NONPEPTIDAL ANTAGONISTS OF THE PEPTIDE-HORMONE CHOLECYSTOKININ
    EVANS, BE
    BOCK, MG
    RITTLE, KE
    DIPARDO, RM
    WHITTER, WL
    VEBER, DF
    ANDERSON, PS
    FREIDINGER, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) : 4918 - 4922
  • [10] DESIGN OF NONPEPTIDAL LIGANDS FOR A PEPTIDE RECEPTOR - CHOLECYSTOKININ ANTAGONISTS
    EVANS, BE
    RITTLE, KE
    BOCK, MG
    DIPARDO, RM
    FREIDINGER, RM
    WHITTER, WL
    GOULD, NP
    LUNDELL, GF
    HOMNICK, CF
    VEBER, DF
    ANDERSON, PS
    CHANG, RSL
    LOTTI, VJ
    CERINO, DJ
    CHEN, TB
    KING, PJ
    KUNKEL, KA
    SPRINGER, JP
    HIRSHFIELD, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (07) : 1229 - 1239